Compare Best Buy Co Inc (BBY) vs Cronos Group Inc (CRON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Best Buy Co Inc vs Cronos Group Inc — how do they compare? Best Buy Co Inc trades at $83.5 (market cap $17.37B), while Cronos Group Inc trades at $3.08 (market cap $1.11B). The key difference: Best Buy Co Inc is far larger — about 15.6× Cronos Group Inc's market cap, and Best Buy Co Inc pays a 4.66% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals.
| BBY | CRON | |
|---|---|---|
Market Cap | $17.37B | $1.11B |
Sector | Consumer Cyclical | Health |
52-Week High | $90.17 | $3.27 |
52-Week Low | $55.52 | $2.30 |
Enterprise Value | $19.75B | $310.67M |
Dividend Yield | 4.66% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Best Buy Co Inc
With $51.8 billion in fiscal 2022 sales, Best Buy is the largest pure-play consumer electronics retailer in the U.S., with roughly 10.6% share of the aggregate market and north of 40% share of offline sales, per our calculations, CTA industry, and Euromonitor data. The firm generates the bulk of its sales in-store, with mobile phones and tablets, computers, and appliances representing its three largest categories. Recent investments in e-commerce fulfillment, accelerated by the COVID-19 pandemic, have seen the U.S. e-commerce channel roughly double from prepandemic levels, with management estimating that it will represent a mid-30% proportion of sales moving forward.
Read more on BBY →About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →
